Click To Register & Receive Our e-Newsletter
We Serve. Westchester, Rockland, New York City, Long Island, Central & Northern NJ.
Our Mission is to lead the fight to cure and treat ALS through global, cutting edge research, and to empower people with Lou Gehrig's Disease and their families to live fuller lives by providing them with compassionate care and support.
There are many ways to contribute to our chapter:
Look here for all of our upcoming community fundraising events.
If you are planning an event to benefit The ALS Association Greater New York Chapter please contact Rebecca Silver-Fisher, Special Events and Marketing Coordinator at (212) 720-3043 or rsilverfisher@als-ny.org.
You can contact Rebecca for information about sponsorship opportunities and community and school fundraising efforts.
An international study led by biologists and neuroscientists from the University of Pennsylvania, published this week in Nature, has identified a new genetic risk factor for amyotrophic lateral sclerosis, which is commonly known as ALS or Lou Gehrig’s disease.
Using yeast and fruit fly as simple, yet rapid and powerful models, and then following up with human DNA screening, the team found evidence that mutations in the ataxin 2 gene were a genetic contributor to the disease. More specifically, the study shows that expansions of a run of the amino acid glutamine in ataxin 2 are associated with an increased risk for ALS, with a frequency of 4.7 percent of ALS cases examined.